Affinity enhancement bivalent morpholino for pretargeting: Initial evidence by surface plasmon resonance

Bioconjugate Chemistry

Volumn 16, Issue 2, 2005, Pages 338-345

  He, Jiang ^a   Liu, Guozheng ^a   Vanderheyden, Jean Luc ^a   Dou, Shuping ^a   Mary, Rusckoswki ^a   Hnatowich, Donald J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CHROMATOGRAPHIC ANALYSIS; DISSOCIATION; EQUILIBRIUM CONSTANTS; ION CHROMATOGRAPHY; ION EXCHANGE; MASS SPECTROMETRY; RATE CONSTANTS;

ANTITUMOR ANTIBODIES; B-Y IONS; DISSOCIATION RATE CONSTANT; EQUILIBRIA CONSTANTS; HYBRIDISATION; IN-VITRO; PYRROLIDINONE; SUBERATE; SURFACE-PLASMON RESONANCE; SYNTHESISED;

SURFACE PLASMON RESONANCE;

DIVALENT CATION; MORPHOLINE DERIVATIVE;

ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; DIMERIZATION; DRUG BINDING; DRUG STRUCTURE; DRUG TARGETING; LIGAND BINDING; MOLECULAR HYBRIDIZATION; STOICHIOMETRY; SURFACE PLASMON RESONANCE;

EID: 15244343397     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc049719c     Document Type: Article

References (35)

1. Goodwin, D. A., Meares, C. F., McTigue, M., Mccall, M. J., and David, G. S. (1986). Rapid localization of haptens in sites containing previously administered antibody for immunoscintigraphy with short half-life tracers [abstract]. J. Nucl. Med. 27, 959-959.
2. Hnatowich, D. J., Virzi, F., and Rusckowski, M. (1987) Investigations of avidin and biotin for imaging applications. J. Nucl. Med. 28, 1294-302.
3. Kuijpers, W. H., Bos, E. S., Kaspersen, F. M., Veeneman, G. H. and van Boeckel, C. A. (1993) Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer. Bioconjugate Chem. 4, 94-102.
4. Hamblett, K. J., Kegley, B. B., Hamlin, D. K., Chyan, M. K., Hyre, D. E., Press, O. W., Wilbur, D. S., and Stayton, P. S. (2002) A streptavidin-biotin binding system that minimizes blocking by endogenous biotin. Bioconjugate Chem. 13, 588-598.
5. Wilbur, D., Pathare, P. M., Hamlin, D. K., and Weerawarna, S. A. (1997) Biotin Reagents for Antibody Pretargeting. 2. Synthesis and in Vitro Evaluation of Biotin Dimers and Trimers for Cross-Linking of Streptavidin. Bioconjugate Chem. 8, 819-832.
6. Karacay H., McBride W. J., Griffiths G. L., Sharkey R. M., Barbet J., Hansen, H. J., and Goldenberg, D. M. (2000) Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a 99mTc-/188Re-labeled peptide. Bioconjugate Chem. 11, 842-854
7. Gruaz-Guyon, A., Janevik-Ivanovska, E., Raguin, O., De Labriolle-Vaylet, C., and Barbet, J. (2001) Radiolabeled bivalent haptens for tumor immunodetection and radioimmunotherapy. Q. J. Nucl. Med. 45, 201-6.
8. Chang, C., Sharkey, R. M., Rossi, E. A., Karacay, H., McBride, W., Hansen, H. J., Chatal, J., Barbet, J., and Goldenberg, D. M. (2002) Molecular advances in pretargeting radioimmunotherapy with bispecific antibodies. Mol. Cancer Ther. 1, 553-563.
9. Cardillo, T. M., Karacay, H., Goldenberg, D. M., Yeldell, D., Chang, C. H., Modrak, D. E., Sharkey, R. M., and Gold, D. V. (2004) Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy. Clin. Cancer Res. 10, 3552-3561.
10. Goodwin, D. A., Meares, C. F., McTigue, M., Chaovapong, W., Diamanti, C. I., Ransone, C. H., and McCall, M. J. (1992) Pretargeted immunoscintigraphy: Effect of hapten valency on murine tumor uptake. J. Nucl. Med. 33, 2006-2013.
11. Hillairet De Boisferon, M., Raguin, O., Thiercelin, C., Dussaillant, M., Rostene, W., Barbet, J., Pelegrin, A., and Gruaz-Guyon, A. (2002) Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model. Bioconjugate Chem. 13, 654-662.
12. Boerman, O. C., van Eerd, J., Oyen, W. J. G., and Corstens, F. H. M. (2002) A 3-Step Pretargeting Strategy to Image Infection. J. Nucl. Med. 42, 1405-1411.
13. Barbet, J., Peltier, P., Bardet, S., Vuillez, J. P., Bachelot, I., Denet, S., Olivier, P., Leccia, F., Corcuff, B., Huglo, D., Proye, C., Rouvier, E., Meyer, P., and Chatal, J. F. (1998) Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. J. Nucl. Med. 39, 1172-1178.
14. Bardies, M., Bardet, S., Faivre-Chauvet, A., Peltier, P., Douillard, J. Y., Mahe, M., Fiche, M., Lisbona, A., Giacalone, F., Meyer, P., Gautherot, E., Rouvier, E.; Barbet, J., and Chatal, J. F. (1996) Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. J. Nucl. Med. 37, 1853-1859.
15. Gautherot, E., Rouvier, E., Daniel, L., Loucif, E., Bouhou, J., Manetti, C., Martin, M., Le Doussal, J. M., and Barbet, J. (2000) Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten. J. Nucl. Med. 41, 480-487.
16. Gestin, J. F., Loussouarn, A., Bardies, M., Gautherot, E., Gruaz-Guyon, A., Sai-Maurel, C., Barbet, J., Curtet, C., Chatal, J. F., and Faivre-Chauvet, A. (2001) Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies. J. Nucl. Med. 42, 146-153.
17. Griffiths, G. L., Chang, C. H., McBride, W. J., Rossi, E. A., Sheerin, A., Tejada, G. R., Karacay, H., Sharkey, R. M., Horak, I. D., Hansen, H. J., and Goldenberg, D. M. (2004) Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates. J. Nucl. Med. 45, 30-39.
18. Hosono, M., Hosono, M. N., Kraeber-Bodere, F., Devys, A., Thedrez, P., Fiche, M., Gautherot, E., Barbet, J., and Chatal, J. F. (1998) Biodistribution and dosimolecular study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten. J. Nucl. Med. 39, 1608-1613.
19. Hosono, M., Hosono, M. N., Kraeber-Bodere, F., Devys, A., Thedrez, P., Faivre-Chauvet, A., Gautherot, E., Barbet, J., and Chatal, J. F. (1999) Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten. J. Nucl. Med. 40, 1216-1221.
20. Kraeber-Bodere, F., Bardet, S., Hoefnagel, C. A., Vieira, M. R., Vuillez, J. P., Murat, A., Ferreira, T. C., Bardies, M., Ferrer, L., Resche, I., Gautherot, E., Rouvier, E., Barbet, J., and Chatal, J. F. (1999) Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial. Clin. Cancer Res. 5(Suppl.), 3190s-3198s.
21. Kraeber-Bodere, F., Faivre-Chauvet, A., Sai-Maurel, C., Campion, L., Fiche, M., Gautherot, E., Le Boterff, J., Barbet, J., Chatal, J. F., and Thedrez, P. (1999) Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab′)2 and pretargeted bivalent hapten and evaluation of repeated injections. Clin Cancer Res. 5(10 Suppl), 3183s-3189s.
22. Sridhar, J., Wei, Z., Nowak, I., Lewin, N. E., Ayers, J. A., Pearce, L. V., Blumberg, P. M., and Kozilowski, A. P. (2003) New bivalent PKC ligands linked by a carbon spacer: Enhancement in binding affinity. J. Med. Chem. 46, 4196-4204.
23. Mang'era, K. O., Liu, G., Wang, Y., Zhang, Y., Liu, N., Gupta, S., Rusckowski, M., and Hnatowitch, D. J. (2001) Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications. Eur. J. Nucl. Med. 28, 1682-1689.
24. Liu, G., Mang'era, K., Liu, N., Gupta, S., Rusckowski, M., and Hnatowich, D. J. (2002) Tumor pretargeting in mice using 99mTc-labeled morpholino, a DNA analog. J. Nucl. Med. 43, 384-391.
25. Liu, G., Liu, C., Zhang, S., He, J., Liu, N., Gupta, S., Rusckowski, M., and Hnatowich, D. J. (2003) Investigations of technetium-99m morpholino pretargeting in mice. Nucl. Med. Commun. 24, 697-705.
26. He, J., Liu, G., Gupta, S., Zhang, Y., Rusckowski, M., and Hnatowich, D. J. (2004) Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept. J. Nucl. Med. 45, 1087-1095.
27. He, J., Liu, G., Zhang, S., Vanderheyden, J.-L., Liu, N., Liu, C., Zhang, Y., Gupta, S., Rusckowski, M., and Hnatowich, D. J. (2003) A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length. Bioconjugate Chem. 14, 1018-1023.
28. Mistrik, P., Moreau, F., and Allen, J. M. (2004) BiaCore analysis of leptin-leptin receptor interaction: evidence for 1:1 stoichiometry. Anal. Biochem. 327, 271-277.
29. Rossi, E. A., Sharkey, R. M., McBride, W., Karacay, H., Zeng, L., Hansen, H. J., Goldenberg, D. M., and Chang, C. H. (2003) Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy. Clin. Cancer Res. 9(10 Pt 2), 3886s-3896s.
30. Pack, P., Muller, K., Zahn, R., and Pluckthun, A. (1995) Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J. Mol. Biol. 246, 28-34.
31. Svensson, H. G., Wedemeyer, W. J., Ekstrom, J. L., Callender, D. R., Kortemme, T., Kim, D. E., Sjobring, U., and Baker, D. (2004) Contributions of amino acid side chains to the kinetics and thermodynamics of the bivalent binding of protein L to Ig kappa light chain. Biochemistry. 43, 2445-2457.
32. Muller, K. M., Arndt, K. M., and Pluckthun, A. (1998) Model and simulation of multivalent binding to fixed ligands. Anal. Biochem. 261, 149-158.
33. Kortt, A. A., Lah, M., Oddie, G. W., Gruen, C. L., Burns, J. E., Pearce, L. A., Atwell, J. L., McCoy, A. J., Howlett, G. J., Metzger, D. W., Webster, R. G., and Hudson, P. J. (1997) Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. Protein Eng. 10, 423-433.
34. Jenkins, J. L., Lee, M. K., Valaitis, A. P., Curtiss, A., and Dean, D. H. (2000) Bivalent sequential binding model of a Bacillus thuringiensis toxin to gypsy moth aminopeptidase N receptor. J. Biol. Chem. 275, 14423-31.
35. Stenberg, E., Persson, B., Roos, H., and Urbaniczky, C. (1991) Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins J. Colloid Interface Sci. 143, 513-526.